SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (1549)2/6/2006 11:29:07 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
Another thing to keep in mind with AGEN is a possible ShortSqzz <g>

Last month the short position was reported at 8.12M with an average trading volume of 255Ks that means there is a Short Ratio around 28.7 or that it will take the whole month of February to take care of the short position at the average present trading volume.

If some positive news come out, or an "upgrade" or a guru's recommendation, we could see a sharp up spike from present levels.

Some of those holding a few QHLBA or QHLCA which trade at less than $1 could make a good profit on a S-SQZ.<g>



To: tuck who wrote (1549)7/16/2007 3:59:39 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
CTIC Was up 18% today after it opened with an UG which has not been closed as yet, albeit it is only trading up 14% at present.

bigcharts.marketwatch.com

The recent up move that started with an UG on July 5 has been helped by the announcement that the interim results of its PII/III of CPOP-R treatment of patients with aggressive NHL.

They said that they plan to report data from RAPID at the ASH meeting in Dec.

Last Dec. they closed their PGT305 for lung cancer & said they were planning on submitting a PGT306 to the FDA.

CTIC Has been trimming its losses for 4 consecutive Qs & the loss for 2007 is expected to be below $3 for the 1st time.<g> The loss for 2008 is expected to be trimmed further to around $2.35/shr.

CTIC Is starting to get off its near term downtrend coming from its April 11 H at $7.52, but it needs to close above that level & actually at $7.80 in order to be able to test its September H at $10.12

bigcharts.marketwatch.com

If it can do that, the next resistance would be at the $14 level.<g>

bigcharts.marketwatch.com

Bernard